RETRACTED: Differential Regulation of the EGFR/PI3K/AKT/PTEN Pathway between Low- and High-Grade Gliomas
Open Access
- 18 December 2021
- journal article
- research article
- Published by MDPI AG in Brain Sciences
- Vol. 11 (12) , 1655
Abstract
Gliomas represent 70% of all central system nervous tumors and are classified according to the degree of malignancy as low- or high-grade. The permanent activation of the EGFR/PI3K/AKT pathway by various genetic or post-translational alterations of EGFR, PI3KCA, and PTEN has been associated with increased proliferation and resistance to apoptosis. The present study aimed to analyze the molecular/genetic changes in the EGFR/PI3K/AKT/PTEN pathway between low-grade and high-grade gliomas in a sample of Colombian patients. A total of 30 samples were tested for PI3K and PTEN mutations, EGFR, PI3K, and AKT gene amplification, AKT, PI3K, BAX, Bcl2 expression levels, and phosphorylation of AKT and PTEN, EGFR and/or PI3K gene amplification was found in 50% of low-grade and 45% of high-grade ones. AKT amplification was found in 25% of the low-grade and 13.6% of the high-grade. The expression of PI3K, AKT, Bcl2, and BAX was increased particularly to a high degree. AKT phosphorylation was found in 66% of low-grade and 31.8% of high-grade. Increased phosphorylation of PTEN was found in 77% low-grade and 66% high-grade. Our results indicate that alterations in the EGFR/PI3K/AKT/PTEN pathway could be important in the initiation and malignant progression of this type of tumor.Keywords
This publication has 42 references indexed in Scilit:
- PTEN promoter methylation and activation of the PI3K/Akt/mTOR pathway in pediatric gliomas and influence on clinical outcomeNeuro-Oncology, 2012
- The Role of Bcl-2 Family Proteins in Therapy Responses of Malignant Astrocytic Gliomas: Bcl2L12 and BeyondThe Scientific World Journal, 2012
- Bcl‐2 promotes malignant progression in a PDGF‐B‐dependent murine model of oligodendrogliomaInternational Journal of Cancer, 2010
- Primary glioblastomas with and without EGFR amplification: Relationship to genetic alterations and clinicopathological featuresNeuropathology, 2009
- Activation of PI3K/mTOR pathway occurs in most adult low-grade gliomas and predicts patient survivalJournal of Neuro-Oncology, 2009
- Descriptive Epidemiology of Cerebral Gliomas in Northwest Greece and Study of Potential Predisposing Factors, 2005–2007Neuroepidemiology, 2009
- Class I PI3K in oncogenic cellular transformationOncogene, 2008
- A population‐based description of glioblastoma multiforme in Los Angeles County, 1974–1999Cancer, 2005
- Mutations of PIK3CA in Anaplastic Oligodendrogliomas, High-Grade Astrocytomas, and MedulloblastomasCancer Research, 2004
- High Frequency of Mutations of the PIK3CA Gene in Human CancersScience, 2004